To coincide with the annual meeting of British Pharmacological Society, senior representatives from two of the country's leading academic societies outlined the case for
drug discovery industry in the UK.
The Canadian
drug discovery industry is still small, especially in comparison to the United States, owing to the lack of big pharmaceutical companies conducting research and development in this country.
Not exact matches
«It just felt like there was this massive amount of waste,» she says, referring to the billions of dollars the pharma
industry annually plunges into
drug discovery, with diminishing results.
These companies were early developers of
drug discovery tools, and were part of an
industry wide acquisition roll - up that resulted in Accelrys.
As an investment, a
drug that is in the
discovery or pre-clinical stage is a very risky proposition, with less than a 1 % chance of getting to market (according to an
industry report published in 2003 by the Pharmaceutical Research and Manufacturers of America).
«These are companies using artificial intelligence in
industries from
drug discovery and cybersecurity to robotics and legal tech.
But there is no
industry I can think of — no sport, no science, no game, no writing, no legal system, no athletic ability, no engineering, no
drug discovery, no awards for scientific achievement, no Fortune 50 companies (companies that actually make something in addition to money), no adventurism, no culinary art, no nothing in which a woman sits above all men in her field.
One because he made a MAJOR, impactful, amazing
discovery that changes the game of genetics, the other because he * already worked in
industry * before he got his PhD and got 3 patents during grad school, one for a marketable
drug.
Zhi Hong, Ribapharm's vice president of
drug discovery, said, «From the pharmaceutical
industry point of view, I see immunotherapy as the most exciting aspect of immunology.»
Recently, though, the
drug discovery components of the business have begun to provide some of the
industry's more intellectually challenging and financially rewarding jobs.
But
industry also looks forward to change, particularly in
drug discovery.
Although the pharmaceutical
industry, like the rest of the business world, has suffered a slowdown, the market research company Frost and Sullivan still expects spending on
drug discovery to expand from US$ 19.6 billion in 2002 to US$ 25.6 billion by 2006, an annual growth rate of about 6 %.
A Career in
Drug Discovery and Development Wolfgang Sadée, professor of pharmacology at Ohio State University, offers an overview of drug discovery in the pharmaceutical industry and outlines the range of opportunities available to students who are interested in moving into this dynamic fi
Drug Discovery and Development Wolfgang Sadée, professor of pharmacology at Ohio State University, offers an overview of
drug discovery in the pharmaceutical industry and outlines the range of opportunities available to students who are interested in moving into this dynamic fi
drug discovery in the pharmaceutical
industry and outlines the range of opportunities available to students who are interested in moving into this dynamic field.
While helping make the entire
industry more productive, these new programs add yet another element to the continuing education of
drug discovery researchers.
To give you a sense of where the arena is headed, we'll also describe over the course of the month new
industry initiatives that are intended to improve the
drug discovery process.
Those moves represent a shift by Pfizer toward a more specialized approach to
drug discovery and follow another trend in the
industry: streamlining R&D by focusing on specific disease areas — a strategy biotechs already employ albeit on a smaller scale.
In the first week of the feature and continuing throughout the month, Next Wave will explore
drug discovery opportunities in
industry by highlighting the experiences of researchers working for larger and more established companies, as well as the motivations of an individual who chose a
drug discovery start - up.
At the same time, my learning curve was steep as I interacted with the talented chemists, expanded my repertoire of techniques (in particular with mass spectroscopy), and generally learned about the
drug -
discovery side of the
industry.
«Usually people say that
drug discovery and development can not happen strictly in the academic environment, that
discovery should be done in academia, and development done elsewhere, such as in
industry,» said Radu.
Now in its 6th consecutive year, Scientific American Worldview: A Global Biotechnology Perspective, has become an international «
industry standard,» linking the frontiers of life science innovation and
drug discovery with the policies and programs driving them forward.
Today, job prospects within computational biology — also known as bioinformatics — seem strong and appear to be growing, buoyed by pharmaceutical and biotech
industries looking to take advantage of reams of genomics data and usher in a new era of
drug discovery.
Lowe, a medical chemist by profession, provides daily commentary on
drug discoveries, the pharmaceutical
industry, and relevant research and news, especially in chemistry.
Although SB 247464 doesn't work with human cells, the
discovery will spur the pharmaceutical
industry's search for protein - mimicking
drugs, says Mark Goldsmith, who studies cytokine receptors at the University of California, San Francisco.
► This week, In the Pipeline, Derek Lowe's popular
drug discovery and the pharma
industry blog, moved to the Science Translational Medicine site.
Tracy began as an
industry researcher and within a year had moved to the
drug -
discovery department at her pharma employer.
Often, though, the financial challenge of
drug discovery leads academic scientists to collaborate with
industry.
Researchers there are convinced that these technologies will increase the chance for serendipitous
discoveries, accelerate the speed of delivering new
drugs to market and advance the
industry as a whole toward personalized medicine.
«We are very strong in
drug discovery, but we don't have a strong local pharmaceutical
industry,» she says.
Nevertheless, Canadian job opportunities in
drug discovery are on the rise, Harack declares, as the local biotechnology
industry enters its «early teen» phase, growing from early stage R&D to development and commercialization.
Working on the premise that scientific research is the foundation of any technology
industry, Hancock and others at UBC are writing a business proposal for an integrative centre for
drug research, with an objective of developing intellectual property in
drug discovery, providing training for
drug discovery researchers, and developing new technologies.
I worked in metabolic disease
drug discovery in the pharmaceutical
industry for more than 22 years.
«While we celebrate the «a ha» moment of scientific
discovery and invention, such moments are only the point of initiation for the basic research required to develop new
drugs,» said Dr. Laura McNamee, the lead author of the paper and a research associate in Bentley's Center for Integration of Science and
Industry.
The pharmaceutical
industry is research and development driven, given that company growth and viability are dependent on the
discovery of new
drug molecules.
The drying
drug pipeline and looming patent cliff, together with the ailing economy, has hit the
drug discovery business hard, forcing the
industry to lay off workers and rethink and restructure its research and development models.
As
industry giants lose patent rights on big - money
drugs such as Lipitor and Plavix, they are looking to offset lost revenues by cutting costs and lowering exposure to the risks and expenses of
drug discovery and development.
I had this
discovery that could undermine a $ 3 billion
industry, not just the
drugs but the entire field of endoscopy.
This has resulted in
industry laboratories dedicated to
drug discovery or human genome research.
«
Industry jobs do tend to prize creativity, but within the confines of a predefined goal,» says Paul M. Matthews, vice president for imaging and head of the GlaxoSmithKline Clinical Imaging Centre in Hammersmith Hospital within the company's
drug discovery division.
«Techniques like this one that enable controlled, remote C - H activation are just beginning to be adopted by
industry, and should provide a boost to
drug discovery and development efforts for many years to come,» Yu said.
The convergence of several factors explains the trend: cheaper genetic sequencing technologies, the
discovery of new oncogenes (genes that can cause a normal cell to become cancerous), a new generation of computers and bioinformatics that can analyze vast amounts of data, and a multibillion - dollar effort by researchers inside and outside the pharma
industry to develop targeted
drugs and companion diagnostics for cancer.
Given how much money there is in the
industry, it is not surprising that biotech is most prominent in
drug discovery and pharmaceuticals.
Essentially, the model for the
drug discovery process in academia is the same as in
industry.
Drug discovery in academia, because of the financial constraints, is on a much smaller scale than
industry and therefore allows «hands - on» experience of several stages in the process as well as more extensive training in a single area.
The role played by organic chemistry in the pharmaceutical
industry continues to be one of the main drivers in the
drug discovery process.
Highlights SciLifeLab DDD platform reaches out to Swedish academia with an
industry - standard infrastructure for academic
drug discovery.
The SGC is a global network of experienced academic and
industry scientists that will contribute expertise in the development of reagents required for target validation and
drug discovery.
12 years of expertise in metabolomics for
drug discovery in the pharmaceutical
industry and in the development of innovative analytical methods for biomarker analysis, with experience in metabolomics and imaging technologies coupling.
The initiative will also allow the CMI to foster new partnerships between academia and
industry, and utilize the individual strengths that each possess to expedite the early stages of small molecule
drug discovery.
To help Gladstone
discoveries successfully cross through the valley of death, the Hellman Family Foundation Alzheimer's Research Program subsidizes the myriad of early - stage, de-risking tests necessary to make a
drug candidate more attractive to pharmaceutical -
industry partners, such as tests that reveal at what concentrations a
drug stops being therapeutic and instead becomes toxic.
This effort will combine academic groundbreaking
discoveries with
drug discovery expertise and development traditionally only found in the pharmaceutical
industry.